about
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsAP-2alpha Inhibits c-MYC Induced Oxidative Stress and Apoptosis in HaCaT Human KeratinocytesBIN1 is a novel MYC-interacting protein with features of a tumour suppressorIdentification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related geneThe proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progressionRSK in tumorigenesis: connections to steroid signaling.Modulation of c-myc, max, and mad gene expression during neural differentiation of embryonic stem cells by all-trans-retinoic acid.MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.New Myc-interacting proteins: a second Myc network emerges.Mechanisms of apoptosis by c-Myc.The role of c-myc in cellular growth control.c-Myc target genes involved in cell growth, apoptosis, and metabolismc-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent pointsThe Max network gone mad.Mechanisms of cyclin-dependent kinase inactivation by progestinsMyc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.Overexpression of c-Myc alters G(1)/S arrest following ionizing radiationCharacterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptorChromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpressionEvolution of the Max and Mlx networks in animals.Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-MycTumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.Analysis of biological selections for high-efficiency gene targeting.The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.Radioprotectants to reduce the risk of radiation-induced carcinogenesis.Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation.DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.MYC-Driven Pathways in Breast Cancer Subtypes.CLOCK promotes 3T3-L1 cell proliferation via Wnt signaling.Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.A large scale genetic analysis of c-Myc-regulated gene expression patterns.Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle.Genomic instability in MycER-activated Rat1A-MycER cells.Decreased ability of cells overexpressing MYC proteins to reduce peroxide and hydroperoxides
P2860
Q24292464-9678C922-346B-4F17-9F8B-D62E90A0A957Q24294722-4A2F22EB-1E55-4D79-81C8-5FDAA854997FQ24318855-3384AA72-71DB-4E59-B05B-C472581CEFAFQ24336084-E06A5D8E-2669-4A47-A2DB-6DF0509D9759Q28565179-A1B12307-FE59-4F5B-8096-D9DD73601D38Q30433106-01319055-F30A-4805-8E44-B3E41638AB2DQ31078047-03E729EB-E044-44EE-90B0-A2DAC89D175EQ33440553-A58689BE-9C58-4B27-A3AD-161D9A2E9322Q33667300-C3A562E9-EAAD-46A2-A9C9-304C7F52C87AQ33667315-040A8DCC-F7DC-42E3-992E-1C6EF38753C2Q33667324-169E9000-22C4-491C-BFD6-2B81A615537DQ33956988-85F47AE8-3101-43F8-BA73-F1D61CC6CEA8Q33958488-B8266697-C263-4398-BB70-9686AEDB898BQ33967079-20C3A6A3-C3F6-458F-96D0-9EEC1D783789Q33993962-A42825DF-9491-4E33-B11C-48B8A0F3B1F2Q34074572-D30E046A-7EFA-4C60-8E64-F9779F8DF5A6Q34324237-B89C442C-0879-482F-ACA1-99FDAA57E3DCQ34449018-40A83FF1-30FF-42BB-AD73-E44D422D70E4Q34786043-CA5E5ECE-7CD8-4DC8-8CE1-975594F01DF9Q35224604-47CC351B-44FF-4C75-99FF-F7F35E4348D3Q35915994-AFB9180B-F005-4E3C-84E8-EF0D89C83631Q36134626-E8B4F4F6-62B3-4355-8BAB-991DC154CAA4Q36405134-5F1F2383-DD31-4FE0-BDE3-5A4A3F062FC4Q36566296-4CFF2E7E-00DC-47CE-9EAA-A868AAE09008Q36678674-6A81998B-CE74-4343-A963-D55BEF90C099Q36780680-50E56474-E862-4688-88AE-DA7D3EC35308Q37623433-DD709C0E-189B-42E6-9AF9-0D6C5FC3D905Q38155924-CA00D2C7-FA04-4C8C-996B-E065D9E67664Q39230218-CF846738-2790-4305-AD5C-CCE60884E03CQ39242131-672E99CD-B26E-4801-B8B9-E4F06DBB2F29Q39401250-8CC4C153-BF19-4ABA-8DF2-A52FC240C468Q39428256-986FE794-75F2-4695-AFFF-D0A15EA94BE3Q39754622-75453ADD-72BC-4A0B-BAD8-6362028D2924Q39757012-EB064076-3099-42BC-B448-DFA5B281EE44Q40677486-A93F19F5-A2B0-431D-9A5B-1A574CF00DF8Q40787477-64ACFA76-12FB-4A1D-8DCB-393720EDE6DFQ40979144-42301BF7-E8D3-46A4-8D21-A761FBB790FFQ41065598-13B909A0-5491-4F89-A0BB-C7831DFA892EQ41178239-561B791D-9F8E-4594-A299-4FEF61D3944CQ41188461-7586BDA7-819A-4A72-8EE7-58F9AD797321
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Effects of c-myc expression on cell cycle progression.
@ast
Effects of c-myc expression on cell cycle progression.
@en
type
label
Effects of c-myc expression on cell cycle progression.
@ast
Effects of c-myc expression on cell cycle progression.
@en
prefLabel
Effects of c-myc expression on cell cycle progression.
@ast
Effects of c-myc expression on cell cycle progression.
@en
P2093
P2860
P356
P1476
Effects of c-myc expression on cell cycle progression
@en
P2093
J M Sedivy
K D Hanson
M R Follansbee
P2860
P304
P356
10.1128/MCB.14.9.5748
P407
P577
1994-09-01T00:00:00Z